Skip to main content

Table 2 Myocardial strain and CMR characteristics of patients and controls

From: Myocardial strain analysis using cardiac magnetic resonance in patients with calpainopathy

 

LGMDA2 patients

(n = 11)

Controls

(n = 11)

p value

Left ventricular parameters

   

 GLS, %

− 22.3 (3.2)

− 21.8 (5.1)

0.38

 GRS, %

50.9 (17)

54.3 (12)

0.59

 GCS, %

− 29.8 (5.2)

− 30 (4.8)

0.86

 LVEF, %

55.9 (2.6)

60.62 (6.6)

0.15

 LVEDV, ml

102.5 (17.4)

155.4.0 (29.1)

< 0.001

 LV mass, g

77.7 (17.2)

112.9 (44.3)

0.04

 LGE, %

0.4 (0.8)

 

Right ventricular parameters

   

 GLS %

− 26.8 (5.8)

− 26.3 (7.2)

0.85

 GLS free wall, %

− 32.3 (5.6)

− 32.7 (7.9)

0.91

 GLS septum %

− 21.3 (5.6)

− 19.9 (6.6)

0.64

 RVEF, %

63.5 (5.8)

60 (6.8)

0.34

 RVFAC, %

46.3 (9)

48 (8)

0.66

 TAPSE, mm

23 (6.1)

28.5 (5)

0.09

 RVEDV, ml

88.5 (19.8)

142.7 (38.4)

0.01

  1. Bold indicates significant between-group differences
  2. Data are presented as mean (SD)
  3. GLS, global longitudinal strain; GRS, global radial strain; GCS, global circumferential strain; LVEF, left ventricular ejection fraction, LVEDV, left ventriclar end-diastolic volume; RVEF, right ventricular ejection fraction; RVFAC, right ventricular fractional area change; TAPSE, tricuspid annular plane systolic excursion; RVEDV, right ventricular end-diastolic volume; LGMD2A, limb girdle muscular dystrophy